<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00588861</url>
  </required_header>
  <id_info>
    <org_study_id>101-U-011</org_study_id>
    <nct_id>NCT00588861</nct_id>
  </id_info>
  <brief_title>Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone Cement</brief_title>
  <official_title>Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Acetabular Shell Using Simplex® or Palacos® Bone Cement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biomet Orthopedics, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to document the clinical outcomes of several devices used in
      total hip replacement, including the Answer® hip stem, the Ranawat/Burnstein® acetabular
      shell, and Simplex® or Palacos® bone cement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to document the clinical outcomes of several devices used in
      total hip replacement, including the Answer® hip stem, the Ranawat/Burnstein® acetabular
      shell, and Simplex® or Palacos® bone cement. It was desirable to see if there were any
      differences in the outcomes of two different types of bone cement in application.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study was terminated due to insufficient data and lack of patient follow-up
  </why_stopped>
  <start_date>September 2002</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>10 Years Post-Operative</time_frame>
    <description>The Harris Hip Score is detailed below as a range. 100 being the highest score, and 0 being the lowest score. 90-100 is considered &quot;Excellent.&quot; 80-89 is considered &quot;Good.&quot; 70-79 is considered &quot;Fair.&quot; Less than 70 is considered &quot;Poor.&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score Pain</measure>
    <time_frame>Pre-Operative, 6 months, 1 year, 2 year, 4 year, 6 year, 8 year, 10 year</time_frame>
    <description>Harris Hip Score Pain is detailed below as mean score for the Harris Hip Score Pain question. 44 being the highest score, and 0 being the lowest score. 44 is considered &quot;None/Ignores.&quot; 40 is considered &quot;Slight/Occasional.&quot; 30 is considered &quot;Mild.&quot; 20 is considered &quot;Moderate.&quot; 10 is considered &quot;Marked.&quot; 0 is considered &quot;Totally Disabled.&quot;</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">400</enrollment>
  <condition>Osteoarthritis, Hip</condition>
  <condition>Traumatic Arthritis of Hip</condition>
  <arm_group>
    <arm_group_label>Answer® hip stem with Simplex Cement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Femoral stem replacement with Answer® hip stem &amp; Simplex Bone Cement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Answer® hip stem with Palacos Cement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Femoral stem replacement with Answer® hip stem &amp; Palacos Bone Cement</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Answer® hip stem</intervention_name>
    <description>Total hip replacement using Palacos® bone cement, the Answer® hip stem and the Ranawat/Burnstein® acetabular shell.</description>
    <arm_group_label>Answer® hip stem with Simplex Cement</arm_group_label>
    <arm_group_label>Answer® hip stem with Palacos Cement</arm_group_label>
    <other_name>Answer Hip Stem</other_name>
    <other_name>Simplex Bone Cement</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Answer® hip stem</intervention_name>
    <description>Total hip replacement using Simplex® bone cement, the Answer® hip stem and the Ranawat/Burnstein® acetabular shell.</description>
    <arm_group_label>Answer® hip stem with Simplex Cement</arm_group_label>
    <arm_group_label>Answer® hip stem with Palacos Cement</arm_group_label>
    <other_name>Answer Hip Stem</other_name>
    <other_name>Palacos Bone Cement</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Noninflammatory degenerative joint disease including osteoarthritis and avascular
             necrosis

          -  Rheumatoid arthritis

          -  Correction of functional deformity

          -  Treatment of non-union, femoral neck fracture, and trochanteric fractures of the
             proximal femur with head involvement, unmanageable using other techniques

        Exclusion Criteria:

          -  Infection, sepsis, and osteomyelitis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ken Beres, MD</last_name>
    <role>Study Director</role>
    <affiliation>Zimmer Biomet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Biomet Orthopedics, LLC</name>
      <address>
        <city>Warsaw</city>
        <state>Indiana</state>
        <zip>46581</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2007</study_first_submitted>
  <study_first_submitted_qc>January 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2008</study_first_posted>
  <results_first_submitted>June 14, 2010</results_first_submitted>
  <results_first_submitted_qc>January 12, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 26, 2012</results_first_posted>
  <last_update_submitted>January 26, 2017</last_update_submitted>
  <last_update_submitted_qc>January 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were recruited by the investigator based on the FDA cleared inclusion/exclusion criteria in the protocol.</recruitment_details>
      <pre_assignment_details>The patients were assigned to each group according to the bone cement used with the implant.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Answer Stem Utilizing Simplex Cement</title>
          <description>Simplex Cement is a bone cement used for implant fixation. It is a powder premixed with antibiotics</description>
        </group>
        <group group_id="P2">
          <title>Answer Stem Utilizing Palacos Cement</title>
          <description>Palacos Cement is bone cement used to secure artificial implants to bone that has a green color in order to improve visualization during implantation.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Pre-Operative</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="202">202 Patients were enrolled, however only 107 contributed preop data.</participants>
                <participants group_id="P2" count="200">200 patients were enrolled, however only 114 contributed preop data.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="107"/>
                <participants group_id="P2" count="114"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="95"/>
                <participants group_id="P2" count="86"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Patients Did Not Complete Preop Data</title>
              <participants_list>
                <participants group_id="P1" count="95"/>
                <participants group_id="P2" count="86"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>6 Months</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="107">107 cases were due at 6 Months, however only 9 returned for follow-up.</participants>
                <participants group_id="P2" count="114">114 cases were due at 6 Months, however only 41 returned for follow-up.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="98"/>
                <participants group_id="P2" count="73"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Patients did not return for follow-up</title>
              <participants_list>
                <participants group_id="P1" count="98"/>
                <participants group_id="P2" count="73"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>1 Year</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="107">107 cases were due at 1 Year, however only 18 returned for follow-up.</participants>
                <participants group_id="P2" count="114">114 cases were due at 1 Year, however only 32 returned for follow-up.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="89"/>
                <participants group_id="P2" count="82"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Patients did not return for follow-up</title>
              <participants_list>
                <participants group_id="P1" count="89"/>
                <participants group_id="P2" count="82"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>2 Years</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="107">107 cases were due at 2 Years, however only 15 returned for follow-up.</participants>
                <participants group_id="P2" count="114">114 cases were due at 2 Years, however only 27 returned for follow-up.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="92"/>
                <participants group_id="P2" count="87"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Patients did not return for follow-up</title>
              <participants_list>
                <participants group_id="P1" count="92"/>
                <participants group_id="P2" count="87"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>4 Years</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="107">107 cases were due at 4 Years, however only 16 returned for follow-up.</participants>
                <participants group_id="P2" count="114">114 cases were due at 4 Years, however only 11 returned for follow-up.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="91"/>
                <participants group_id="P2" count="103"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Patients did not return for follow-up</title>
              <participants_list>
                <participants group_id="P1" count="91"/>
                <participants group_id="P2" count="103"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>6 Years</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="107">107 cases were due at 6 Years, however only 3 returned for follow-up.</participants>
                <participants group_id="P2" count="114">114 cases were due at 6 Years, however only 5 returned for follow-up.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="104"/>
                <participants group_id="P2" count="109"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Patients did not return for follow-up</title>
              <participants_list>
                <participants group_id="P1" count="104"/>
                <participants group_id="P2" count="109"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>8 Years</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="107">107 cases were due at 8 Years, however only 2 returned for follow-up.</participants>
                <participants group_id="P2" count="114">114 cases were due at 8 Years, however no patients returned for follow-up.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="105"/>
                <participants group_id="P2" count="114"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Patients did not return for follow-up</title>
              <participants_list>
                <participants group_id="P1" count="105"/>
                <participants group_id="P2" count="114"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>10 Years</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="107">107 cases were due at 10 Years, however no patients returned for follow-up.</participants>
                <participants group_id="P2" count="114">114 cases were due at 10 Years, however no patients returned for follow-up.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="107"/>
                <participants group_id="P2" count="114"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Incomplete due to study termination</title>
              <participants_list>
                <participants group_id="P1" count="107"/>
                <participants group_id="P2" count="114"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Answer Stem Utilizing Simplex Cement</title>
          <description>Simplex Cement is a bone cement used for implant fixation. It is a powder premixed with antibiotics</description>
        </group>
        <group group_id="B2">
          <title>Answer Stem Utilizing Palacos Cement</title>
          <description>Palacos Cement is bone cement used to secure artificial implants to bone that has a green color in order to improve visualization during implantation.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="202"/>
            <count group_id="B2" value="200"/>
            <count group_id="B3" value="402"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73" lower_limit="46" upper_limit="93"/>
                    <measurement group_id="B2" value="76" lower_limit="54" upper_limit="95"/>
                    <measurement group_id="B3" value="75" lower_limit="46" upper_limit="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="127"/>
                    <measurement group_id="B2" value="142"/>
                    <measurement group_id="B3" value="269"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="75"/>
                    <measurement group_id="B2" value="58"/>
                    <measurement group_id="B3" value="133"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Secondary</type>
        <title>Harris Hip Score Pain</title>
        <description>Harris Hip Score Pain is detailed below as mean score for the Harris Hip Score Pain question. 44 being the highest score, and 0 being the lowest score. 44 is considered &quot;None/Ignores.&quot; 40 is considered &quot;Slight/Occasional.&quot; 30 is considered &quot;Mild.&quot; 20 is considered &quot;Moderate.&quot; 10 is considered &quot;Marked.&quot; 0 is considered &quot;Totally Disabled.&quot;</description>
        <time_frame>Pre-Operative, 6 months, 1 year, 2 year, 4 year, 6 year, 8 year, 10 year</time_frame>
        <population>This population represents patients that returned for follow-up per protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Answer Stem Utilizing Simplex Cement</title>
            <description>Simplex Cement is a bone cement used for implant fixation. It is a powder premixed with antibiotics</description>
          </group>
          <group group_id="O2">
            <title>Answer Stem Utilizing Palacos Cement</title>
            <description>Palacos Cement is bone cement used to secure artificial implants to bone that has a green color in order to improve visualization during implantation.</description>
          </group>
        </group_list>
        <measure>
          <title>Harris Hip Score Pain</title>
          <description>Harris Hip Score Pain is detailed below as mean score for the Harris Hip Score Pain question. 44 being the highest score, and 0 being the lowest score. 44 is considered &quot;None/Ignores.&quot; 40 is considered &quot;Slight/Occasional.&quot; 30 is considered &quot;Mild.&quot; 20 is considered &quot;Moderate.&quot; 10 is considered &quot;Marked.&quot; 0 is considered &quot;Totally Disabled.&quot;</description>
          <population>This population represents patients that returned for follow-up per protocol.</population>
          <units>Mean Hip Pain</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="202"/>
                <count group_id="O2" value="200"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-Operative Harris Hip Score Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.89" spread="7.64"/>
                    <measurement group_id="O2" value="14.74" spread="7.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Month Harris Hip Score Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.78" spread="4.06"/>
                    <measurement group_id="O2" value="36.25" spread="9.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year Harris Hip Score Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.89" spread="9.54"/>
                    <measurement group_id="O2" value="37.76" spread="9.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 Year Harris Hip Score Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.93" spread="9.47"/>
                    <measurement group_id="O2" value="34.59" spread="10.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 Year Harris Hip Score Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.38" spread="9.78"/>
                    <measurement group_id="O2" value="41.27" spread="4.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Year Harris Hip Score Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.00" spread="0"/>
                    <measurement group_id="O2" value="42.00" spread="2.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 Year Harris Hip Score Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.00" spread="9.90"/>
                    <measurement group_id="O2" value="NA">No patients were analyzed at this time interval</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Harris Hip Score</title>
        <description>The Harris Hip Score is detailed below as a range. 100 being the highest score, and 0 being the lowest score. 90-100 is considered &quot;Excellent.&quot; 80-89 is considered &quot;Good.&quot; 70-79 is considered &quot;Fair.&quot; Less than 70 is considered &quot;Poor.&quot;</description>
        <time_frame>10 Years Post-Operative</time_frame>
        <population>This population represents patients that returned for follow-up per protocol. Because no patients returned at the primary outcome measure time frame (10 years), 0 patients were analyzed at 10 years.</population>
        <group_list>
          <group group_id="O1">
            <title>Answer Stem Utilizing Simplex Cement</title>
            <description>Simplex Cement is a bone cement used for implant fixation. It is a powder premixed with antibiotics</description>
          </group>
          <group group_id="O2">
            <title>Answer Stem Utilizing Palacos Cement</title>
            <description>Palacos Cement is bone cement used to secure artificial implants to bone that has a green color in order to improve visualization during implantation.</description>
          </group>
        </group_list>
        <measure>
          <title>Harris Hip Score</title>
          <description>The Harris Hip Score is detailed below as a range. 100 being the highest score, and 0 being the lowest score. 90-100 is considered &quot;Excellent.&quot; 80-89 is considered &quot;Good.&quot; 70-79 is considered &quot;Fair.&quot; Less than 70 is considered &quot;Poor.&quot;</description>
          <population>This population represents patients that returned for follow-up per protocol. Because no patients returned at the primary outcome measure time frame (10 years), 0 patients were analyzed at 10 years.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>8 Years</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Answer Stem Utilizing Simplex Cement</title>
          <description>Simplex Cement is a bone cement used for implant fixation. It is a powder premixed with antibiotics</description>
        </group>
        <group group_id="E2">
          <title>Answer Stem Utilizing Palacos Cement</title>
          <description>Palacos Cement is bone cement used to secure artificial implants to bone that has a green color in order to improve visualization during implantation.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="202"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="200"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="202"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="200"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Deep infection &lt; 6 weeks</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="202"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="200"/>
              </event>
              <event>
                <sub_title>Deep infection &gt; 6 weeks</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="202"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="200"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dislocation</sub_title>
                <counts group_id="E1" events="31" subjects_affected="9" subjects_at_risk="202"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="200"/>
              </event>
              <event>
                <sub_title>Femoral loosening</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="202"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="200"/>
              </event>
              <event>
                <sub_title>Femoral, acetabular loosening and instability</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="202"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="200"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Revision with all components removed and re-implantation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="202"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="200"/>
              </event>
              <event>
                <sub_title>I&amp;D, exchange of poly liner</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="202"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="200"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="202"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="200"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="202"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="200"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can conduct a pre-publication review of articles, papers, or presentations which the PI desires to publish. Any such review must be completed by sponsor within thirty (30)days of the submission of the request. The PI must include whatever credits the sponsor deems necessary or appropriate to disclose its proprietary interest to the material disclosed in the article, paper or presentation.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Study was terminated prematurely after sponsor no longer distributed the products involved and follow-up failed to produce sufficient data to be analyzed.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Nick Higdon, Clinical Research Specialist</name_or_title>
      <organization>Biomet Manufacturing</organization>
      <phone>1-800-348-9500 ext 3047</phone>
      <email>nicholas.higdon@biomet.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

